Diagnostic utility of rapid sequencing in critically ill infants: a systematic review and meta-analysis

References

• Yang L, Liu X, Li Z, et al. Genetic aetiology of early infant deaths in a neonatal intensive care unit. J Med Genet. 2020 Mar;57(3):169–177.
   PubMed Web of Science ®Google Scholar
• Kingsmore SF, Henderson A, Owen MJ, et al. Measurement of genetic diseases as a cause of mortality in infants receiving whole genome sequencing. NPJ Genom Med. 2020;5(1):49.
   PubMed Web of Science ®Google Scholar
• van Diemen CC, Kerstjens-Frederikse WS, Bergman KA, et al. Rapid targeted genomics in critically Ill newborns. Pediatrics. 2017 Oct;140(4). DOI:10.1542/peds.2016-2854.
   PubMed Web of Science ®Google Scholar
• Clark MM, Stark Z, Farnaes L, et al., Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases. NPJ Genom Med. 2018;3(1):16.
   PubMedGoogle Scholar
• Saunders CJ, Miller NA, Soden SE, et al. Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci Transl Med. 2012 Oct 3;4(154):154ra135.
   PubMed Web of Science ®Google Scholar
• Willig LK, Petrikin JE, Smith LD, et al. Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings. Lancet Respir Med. 2015 May;3(5):377–387.
   PubMed Web of Science ®Google Scholar
• Stark Z, Tan TY, Chong B, et al. A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders. Genet Med. 2016 Nov;18(11):1090–1096.
   PubMed Web of Science ®Google Scholar
• Chung CCY, Leung GKC, Mak CCY, et al. Rapid whole-exome sequencing facilitates precision medicine in paediatric rare disease patients and reduces healthcare costs. Lancet Reg Health West Pac. 2020 Aug;1:100001.
   PubMedGoogle Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clin Res Ed). 2009 Jul 21;339(jul21 1):b2700.
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010 Sep;25(9):603–605.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Altman DG, Gøtzsche PC, et al. The cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ (Clin Res Ed). 2011 Oct 18;343(oct18 2):d5928.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002 Jun 15;21(11):1539–1558.
   PubMed Web of Science ®Google Scholar
• Baujat B, Mahé C, Pignon JP, et al. A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials. Stat Med. 2002 Sep 30;21(18):2641–2652.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res Ed). 1997 Sep 13;315(7109):629–634.
   PubMed Web of Science ®Google Scholar
• Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000 Jun;56(2):455–463.
   PubMed Web of Science ®Google Scholar
• Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol. 2000 Nov;53(11):1119–1129.
   PubMed Web of Science ®Google Scholar
• Meng L, Pammi M, Saronwala A, et al. Use of exome sequencing for infants in intensive care units: ascertainment of severe single-gene disorders and effect on medical management. JAMA Pediatr. 2017 Dec 4;171(12):e173438.
   PubMed Web of Science ®Google Scholar
• Petrikin JE, Cakici JA, Clark MM, et al. The NSIGHT1-randomized controlled trial: rapid whole-genome sequencing for accelerated etiologic diagnosis in critically ill infants. NPJ Genom Med. 2018;3(1):6.
   PubMedGoogle Scholar
• Farnaes L, Hildreth A, Sweeney NM, et al. Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization. NPJ Genom Med. 2018;3(1):10.
   PubMedGoogle Scholar
• Stark Z, Lunke S, Brett GR, et al. Meeting the challenges of implementing rapid genomic testing in acute pediatric care. Genet Med. 2018 Dec;20(12):1554–1563.
   PubMed Web of Science ®Google Scholar
• Mestek-Boukhibar L, Clement E, Jones WD, et al. Rapid Paediatric Sequencing (RaPS): comprehensive real-life workflow for rapid diagnosis of critically ill children. J Med Genet. 2018 Nov;55(11):721–728.
   PubMed Web of Science ®Google Scholar
• Kingsmore SF, Cakici JA, Clark MM, et al. A randomized, controlled trial of the analytic and diagnostic performance of singleton and trio, rapid genome and exome sequencing in ill infants. Am J Hum Genet. 2019 Oct 3;105(4):719–733.
   PubMed Web of Science ®Google Scholar
• French CE, Delon I, Dolling H, et al. Whole genome sequencing reveals that genetic conditions are frequent in intensively ill children. Intensive Care Med. 2019 May;45(5):627–636.
   PubMed Web of Science ®Google Scholar
• Gubbels CS, VanNoy GE, Madden JA, et al. Prospective, phenotype-driven selection of critically ill neonates for rapid exome sequencing is associated with high diagnostic yield. Genet Med. 2020 Apr;22(4):736–744.
   PubMed Web of Science ®Google Scholar
• Elliott AM, du Souich C, Lehman A, et al. RAPIDOMICS: rapid genome-wide sequencing in a neonatal intensive care unit-successes and challenges. Eur J Pediatr. 2019 Aug;178(8):1207–1218.
   PubMed Web of Science ®Google Scholar
• Wang H, Lu Y, Dong X, et al. Optimized trio genome sequencing (OTGS) as a first-tier genetic test in critically ill infants: practice in China. Hum Genet. 2020 Apr;139(4):473–482.
   PubMed Web of Science ®Google Scholar
• Wu B, Kang W, Wang Y, et al. Application of full-spectrum rapid clinical genome sequencing improves diagnostic rate and clinical outcomes in critically Ill infants in the China Neonatal Genomes Project. Crit Care Med. 2021 Oct 1;49(10):1674–1683.
   PubMed Web of Science ®Google Scholar
• Dimmock D, Caylor S, Waldman B, et al. Project Baby Bear: rapid precision care incorporating rWGS in 5 California children’s hospitals demonstrates improved clinical outcomes and reduced costs of care. Am J Hum Genet. 2021 Jul 1;108(7):1231–1238.
   PubMed Web of Science ®Google Scholar
• Lunke S, Eggers S, Wilson M, et al. Feasibility of ultra-rapid exome sequencing in critically ill infants and children with suspected monogenic conditions in the Australian Public Health Care System. Jama. 2020 Jun 23;323(24):2503–2511.
   PubMed Web of Science ®Google Scholar
• Wells CF, Boursier G, Yauy K, et al. Rapid exome sequencing in critically ill infants: implementation in routine care from French regional hospital’s perspective. Eur J Hum Genet. 2022 Jun 22;30(9):1076–1082.
   PubMed Web of Science ®Google Scholar
• Wu ET, Hwu WL, Chien YH, et al. Critical trio exome benefits in-time decision-making for pediatric patients with severe illnesses. Pediatr Crit Care Med. 2019 Nov;20(11):1021–1026.
   PubMed Web of Science ®Google Scholar
• Śmigiel R, Biela M, Szmyd K, et al. Rapid whole-exome sequencing as a diagnostic tool in a neonatal/pediatric intensive care unit. J Clin Med. 2020 Jul 13;9(7):2220.
   Web of Science ®Google Scholar
• Wang H, Qian Y, Lu Y, et al., Clinical utility of 24-h rapid trio-exome sequencing for critically ill infants. NPJ Genom Med. 2020;5(1):20.
   PubMed Web of Science ®Google Scholar
• Maron JL, Kingsmore SF, Wigby K, et al. Novel variant findings and challenges associated with the clinical integration of genomic testing: an interim report of the genomic medicine for ill neonates and infants (GEMINI) study. JAMA Pediatr. 2021 May 1;175(5):e205906.
   PubMed Web of Science ®Google Scholar
• Ouyang X, Zhang Y, Zhang L, et al. Clinical utility of rapid exome sequencing combined with mitochondrial DNA sequencing in critically ill pediatric patients with suspected genetic disorders. Front Genet. 2021;12:725259.
   PubMed Web of Science ®Google Scholar
• Denommé-Pichon AS, Vitobello A, Olaso R, et al. Accelerated genome sequencing with controlled costs for infants in intensive care units: a feasibility study in a French hospital network. Eur J Hum Genet. 2022 May;30(5):567–576.
   PubMed Web of Science ®Google Scholar
• Alfares A, Aloraini T, Subaie LA, et al. Whole-genome sequencing offers additional but limited clinical utility compared with reanalysis of whole-exome sequencing. Genet Med. 2018 Nov;20(11):1328–1333.
   PubMed Web of Science ®Google Scholar
• Nohr EA, Liew Z. How to investigate and adjust for selection bias in cohort studies. Acta Obstet Gynecol Scand. 2018 Apr;97(4):407–416.
   PubMed Web of Science ®Google Scholar
• Xiao F, Yan K, Zhou W. Methadone versus morphine treatment outcomes in neonatal abstinence syndrome: a meta-analysis. J Paediatr Child Health. 2019 Oct;55(10):1177–1182.
   PubMed Web of Science ®Google Scholar
• Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med. 2001 Dec 4;135(11):982–989.
   PubMed Web of Science ®Google Scholar
• Turner RM, Bird SM, Higgins JP. The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews. PloS One. 2013;8(3):e59202.
   PubMed Web of Science ®Google Scholar
• Manickam K, McClain MR, Demmer LA, et al. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021 Nov;23(11):2029–2037.
   PubMed Web of Science ®Google Scholar